Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 17, 2018 17:15 ET | Source: Sientra, Inc.

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SANTA BARBARA, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on August 16, 2018, the...
August 10, 2018 16:01 ET | Source: Sientra, Inc.

Sientra Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SANTA BARBARA, Calif., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq:SIEN) (the “Company”) today announced that on August 8, 2018, Paul Little received an equity award grant from the...
August 07, 2018 16:01 ET | Source: Sientra, Inc.

Sientra Reports Second Quarter 2018 Financial Results

Achieves Record Net Sales of $17.6 Million Appoints Patrick F. Williams to General Manager of miraDry Business Segment Appoints Aesthetics Veteran Paul Little as Chief Financial Officer SANTA...
July 25, 2018 08:00 ET | Source: Sientra, Inc.

Sientra to Present at the Canaccord 38th Annual Growth Stock Conference

SANTA BARBARA, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of the management team are scheduled to present at...
July 24, 2018 16:01 ET | Source: Sientra, Inc.

Sientra® to Release Second Quarter 2018 Financial Results on August 7, 2018

SANTA BARBARA, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its...
June 04, 2018 16:01 ET | Source: Sientra, Inc.

Sientra to Present at the William Blair 38th Annual Growth Stock Conference

SANTA BARBARA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that Jeff Nugent, President and Chief Executive Officer, and...
May 09, 2018 16:01 ET | Source: Sientra, Inc.

Sientra Reports First Quarter 2018 Financial Results

Achieves Highest Net Sales in Company’s History Received FDA Approval of PMA Supplement Launched OPUS™ Branded Breast Products and miraDry fresh™ Enhanced Protocol Completed Upsized Follow-on...
May 07, 2018 16:01 ET | Source: Sientra, Inc.

Sientra, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option

SANTA BARBARA, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced the closing of its previously...
May 04, 2018 16:01 ET | Source: Sientra, Inc.

Sientra® to Release First Quarter 2018 Financial Results on Wednesday, May 9, 2018

SANTA BARBARA, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its first...
May 03, 2018 06:00 ET | Source: Sientra, Inc.

Sientra Announces Pricing of Upsized Public Offering of Common Stock

SANTA BARBARA, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced the upsizing and pricing of its...